Successful procedures for the first enrolled patients in our PRECISE-BTN clinical study for the treatment of benign thyroid nodules (BTNs) marks a significant milestone not only for Pulse Biosciences ...
Pulse Biosciences, Inc., a novel bioelectric medicine company progressing Nano-Pulse Stimulation TM technology, announced today that on December 31, 2020, it delivered a notice of redemption to ...
HAYWARD, Calif.---- Pulse Biosciences, Inc., a novel bioelectric medicine company, today announced that it has commenced its previously-announced rights offering of up to 4,279,600 of units at ...
About Pulse Biosciences® Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve and extend the lives of patients.
Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The Company’s proprietary CellFX ...
A look at the shareholders of Pulse Biosciences, Inc. (NASDAQ:PLSE) can tell us which group is most powerful. Institutions often own shares in more established companies, while it's not unusual to ...
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced that it intends to ...
Operator: Greetings, and welcome to the Pulse Biosciences First Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
PULSE BIOSCIENCES, INC. 競合他社・同業他社分析 - Industrial Applications and Services セクター
Our AI model demonstrates 26% historical accuracy for PLSE predictions, based on advanced machine learning algorithms trained on over 10 years of market data.
VAR_0__株価予測に影響を与える要因は何か?
当社の分析では、PULSE BIOSCIENCES, INC.の財務指標、Industrial Applications and Servicesセクターの動向、市場センチメント、テクニカル指標、業績データ、株価に影響を与えるマクロ経済要因を考慮しています。